COLLEGIUM PHARMACEUTICAL, INC (COLL)

Latest Insider Confidence Score

2026Q1

51.6
Bullish

Company insider confidence (by quarter)

2015Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Rubric Capital Management LP 10% Owner 3,132,743 Aug 15, 2025
Rosen David Efraim 10% Owner 3,132,743 Aug 15, 2025
Coulter James G Other 2,532,982 May 14, 2015
Bonderman David Other 2,532,982 May 14, 2015
TPG Group Holdings (SBS) Advisors, Inc. Other 2,532,982 May 14, 2015

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 3, 2026 Mar 5, 2026 Dreyer Scott EVP & Chief Commercial Officer Sell 8.8 -49,976 -41.05% ✓ $2M
Feb 10, 2026 Feb 12, 2026 Dieter David EVP & General Counsel Sell 95.0 +28,418 41.27% ✗ $130K
Feb 10, 2026 Feb 12, 2026 Karnani Vikram CEO Sell 97.5 +100,499 103.22% ✗ $528.1K
Feb 10, 2026 Feb 12, 2026 Smith Thomas B EVP and Chief Medical Officer Sell 97.5 +19,607 27.60% ✗ $815.1K
Feb 10, 2026 Feb 12, 2026 Tupper Colleen CFO Sell 100.0 +20,615 16.27% ✗ $1.8M
Feb 10, 2026 Feb 12, 2026 Dreyer Scott EVP & Chief Commercial Officer Sell 100.0 +18,133 17.50% ✗ $1.5M
Dec 8, 2025 Dec 10, 2025 Dreyer Scott EVP & Chief Commercial Officer Sell 22.5 -17,600 -14.52% ✓ $847.9K
Dec 5, 2025 Dec 9, 2025 Balice-Gordon Rita J. Director Sell 22.5 -3,650 -6.49% ✗ $171.7K
Nov 12, 2025 Nov 14, 2025 Karnani Vikram CEO Sell 40.0 -8,983 -8.48% ✗ $425.3K
Nov 12, 2025 Nov 14, 2025 Fallon John A. Director Sell 17.5 -34,853 -35.03% ✗ $1.6M
Nov 6, 2025 Nov 7, 2025 Tupper Colleen CFO Sell 15.0 -30,000 -19.15% ✓ $1.2M
Aug 29, 2025 Sep 3, 2025 Smith Thomas B EVP and Chief Medical Officer Sell 20.0 -17,478 -19.92% ✗ $671.6K
Aug 18, 2025 Aug 20, 2025 Dreyer Scott EVP & Chief Commercial Officer Sell 22.5 -16,389 -13.66% ✓ $626.2K
Aug 15, 2025 Aug 19, 2025 SANTINI GINO Director Sell 22.5 -5,405 -5.38% ✗ $201K
Aug 13, 2025 Aug 15, 2025 Dreyer Scott EVP & Chief Commercial Officer Sell 37.5 -4,861 -4.48% ✓ $184.9K
Aug 13, 2025 Aug 15, 2025 Rubric Capital Management LP 10% Owner Sell 30.0 -25,000 -0.79% ✗ $946.3K
Aug 15, 2025 Rubric Capital Management LP 10% Owner Neutral 52.5 - 0.00% ✗ -
Aug 8, 2025 Aug 12, 2025 Freund John Gordon Director Sell 20.0 -11,659 -10.22% ✗ $400.6K
Jun 9, 2025 Jun 11, 2025 Freund John Gordon Director Sell 22.5 -6,601 -5.47% ✗ $202.1K
May 15, 2025 May 19, 2025 Fallon John A. Director Neutral 90.0 +9,791 17.85% ✗ -
May 15, 2025 May 19, 2025 Lurker Nancy Director Neutral 90.0 +9,791 76.94% ✗ -
May 15, 2025 May 19, 2025 BOHLIN GAREN G Director Neutral 90.0 +9,791 18.66% ✗ -
May 15, 2025 May 19, 2025 Balice-Gordon Rita J. Director Neutral 90.0 +9,791 21.06% ✗ -
May 15, 2025 May 19, 2025 Freund John Gordon Director Neutral 90.0 +9,791 10.21% ✗ -
May 15, 2025 May 19, 2025 SANTINI GINO Director Neutral 90.0 +9,791 12.94% ✗ -
May 15, 2025 May 19, 2025 Paya Carlos V Director Neutral 90.0 +19,582 100.00% ✗ -
May 19, 2025 Paya Carlos V Director Neutral 52.5 - 0.00% ✗ -
Mar 20, 2025 Mar 24, 2025 Tupper Colleen CFO Sell 37.5 -7,602 -4.63% ✓ $228.3K
Mar 20, 2025 Mar 24, 2025 Dreyer Scott EVP & Chief Commercial Officer Sell 17.5 -20,808 -16.72% ✓ $624.8K
Mar 17, 2025 Mar 19, 2025 Dieter David EVP & General Counsel Neutral 90.0 +68,449 100.00% ✗ -
Mar 19, 2025 Dieter David EVP & General Counsel Neutral 52.5 - 0.00% ✗ -
Mar 11, 2025 Mar 18, 2025 Dreyer Scott EVP & Chief Commercial Officer Sell 22.5 -15,387 -10.83% ✓ $461.7K
Mar 14, 2025 Mar 18, 2025 Tupper Colleen CFO Sell 51.3 -977 -0.59% ✓ $29.3K
Mar 14, 2025 Mar 18, 2025 Dreyer Scott EVP & Chief Commercial Officer Sell 45.0 -2,255 -1.78% ✓ $67.7K
Mar 6, 2025 Mar 13, 2025 Dreyer Scott EVP & Chief Commercial Officer Sell 22.5 -15,387 -10.83% ✓ $461.7K
Mar 11, 2025 Mar 13, 2025 Tupper Colleen CFO Sell 30.0 -10,445 -5.95% ✓ $313.4K
Mar 6, 2025 Mar 10, 2025 Tupper Colleen CFO Sell 45.0 -3,453 -1.93% ✓ $103.6K
Mar 6, 2025 Mar 10, 2025 Dreyer Scott EVP & Chief Commercial Officer Sell 37.5 -5,643 -3.82% ✓ $169.3K
Mar 4, 2025 Mar 6, 2025 Kuhlmann Shirley R. EVP and General Counsel Sell 17.5 -86,067 -44.32% ✗ $2.4M
Feb 10, 2025 Feb 12, 2025 Heffernan Michael Thomas Director Neutral 90.0 +4,820 10.59% ✗ -
Feb 10, 2025 Feb 12, 2025 Smith Thomas B EVP and Chief Medical Officer Sell 95.0 +33,178 60.81% ✗ $180K
Feb 10, 2025 Feb 12, 2025 Dreyer Scott EVP & Chief Commercial Officer Sell 97.5 +41,804 39.47% ✗ $904.1K
Feb 10, 2025 Feb 12, 2025 Tupper Colleen CFO Sell 97.5 +48,299 36.91% ✗ $928.6K
Feb 10, 2025 Feb 12, 2025 Kuhlmann Shirley R. EVP and General Counsel Sell 100.0 +35,020 29.38% ✗ $1.1M
Feb 4, 2025 Feb 5, 2025 Lurker Nancy Director Neutral 90.0 +12,726 100.00% ✗ -
Feb 5, 2025 Lurker Nancy Director Neutral 52.5 - 0.00% ✗ -
Jan 10, 2025 Jan 14, 2025 Kuhlmann Shirley R. EVP and General Counsel Sell 17.5 -27,500 -18.75% ✓ $908.6K
Nov 12, 2024 Nov 14, 2024 Karnani Vikram CEO Neutral 90.0 +105,972 100.00% ✗ -
Nov 14, 2024 Karnani Vikram CEO Neutral 52.5 - 0.00% ✗ -
Sep 13, 2024 Sep 17, 2024 Smith Thomas B EVP and Chief Medical Officer Sell 20.0 -9,593 -15.13% ✗ $351.3K
Sep 5, 2024 Sep 6, 2024 Kuhlmann Shirley R. EVP and General Counsel Sell 20.0 -20,225 -14.51% ✗ $773.8K
Jun 3, 2024 Jun 5, 2024 Kuhlmann Shirley R. EVP and General Counsel Sell 17.5 -25,000 -15.21% ✓ $814.2K
May 28, 2024 May 29, 2024 Tupper Colleen CFO Sell 22.5 -19,710 -13.09% ✓ $674.4K
May 23, 2024 May 28, 2024 Dreyer Scott EVP & Chief Commercial Officer Sell 17.5 -108,016 -30.61% ✗ $3.7M
May 16, 2024 May 16, 2024 SANTINI GINO Director Neutral 90.0 +7,693 11.32% ✗ -
May 16, 2024 May 16, 2024 Melincoff Gwen A Director Neutral 90.0 +7,693 17.18% ✗ -
May 16, 2024 May 16, 2024 McFarlane Neil F. Director Neutral 90.0 +7,693 18.46% ✗ -
May 16, 2024 May 16, 2024 Freund John Gordon Director Neutral 85.0 +7,693 8.72% ✗ -
May 16, 2024 May 16, 2024 Fallon John A. Director Neutral 90.0 +7,693 16.32% ✗ -
May 16, 2024 May 16, 2024 Balice-Gordon Rita J. Director Neutral 90.0 +7,693 19.83% ✗ -
May 16, 2024 May 16, 2024 Heffernan Michael Thomas Director Neutral 90.0 +7,693 20.34% ✗ -
May 14, 2024 May 16, 2024 BOHLIN GAREN G Director Sell 20.0 -21,292 -28.87% ✗ $936.3K
Feb 29, 2024 Mar 4, 2024 Smith Thomas B EVP and Chief Medical Officer Sell 26.3 -995 -1.54% ✗ $36.6K
Feb 26, 2024 Feb 28, 2024 Dreyer Scott EVP & Chief Commercial Officer Sell 30.0 -10,000 -6.72% ✓ $364.3K
Feb 12, 2024 Feb 14, 2024 Tupper Colleen CFO Sell 97.5 +45,135 42.81% ✗ $887K
Feb 12, 2024 Feb 14, 2024 Dreyer Scott EVP & Chief Commercial Officer Sell 100.0 +37,596 33.77% ✗ $1M
Feb 12, 2024 Feb 14, 2024 Smith Thomas B EVP and Chief Medical Officer Sell 95.0 +32,224 100.14% ✗ $107.8K
Feb 12, 2024 Feb 14, 2024 Kuhlmann Shirley R. EVP and General Counsel Sell 100.0 +44,891 37.56% ✗ $1.1M
Feb 12, 2024 Feb 14, 2024 Ciaffoni Joseph CEO Sell 100.0 +169,867 61.77% ✗ $4.3M
Jan 16, 2024 Jan 18, 2024 Dreyer Scott EVP & Chief Commercial Officer Sell 17.5 -23,560 -17.47% ✓ $760.5K
Dec 21, 2023 Dec 22, 2023 Ciaffoni Joseph CEO Sell 45.0 -4,357 -1.56% ✓ $132.4K
Dec 18, 2023 Dec 20, 2023 Ciaffoni Joseph CEO Sell 23.8 -68,768 -7.69% ✓ $2.1M
Nov 27, 2023 Nov 29, 2023 Kuhlmann Shirley R. EVP and General Counsel Sell 17.5 -25,600 -17.64% ✓ $660K
Jun 26, 2023 Jun 28, 2023 Kuhlmann Shirley R. EVP and General Counsel Sell 22.5 -17,984 -13.08% ✓ $390.6K
Jun 1, 2023 Jun 2, 2023 Ciaffoni Joseph CEO Sell 15.0 -62,544 -18.53% ✓ $1.4M
May 30, 2023 Jun 1, 2023 Ciaffoni Joseph CEO Sell 15.0 -62,543 -15.63% ✓ $1.4M
May 18, 2023 May 19, 2023 Balice-Gordon Rita J. Director Neutral 90.0 +9,792 33.76% ✗ -
May 18, 2023 May 19, 2023 McFarlane Neil F. Director Neutral 90.0 +9,792 30.72% ✗ -
May 18, 2023 May 19, 2023 Heffernan Michael Thomas Director Neutral 90.0 +9,792 34.94% ✗ -
May 18, 2023 May 19, 2023 Freund John Gordon Director Neutral 90.0 +9,792 12.49% ✗ -
May 18, 2023 May 19, 2023 Fallon John A. Director Neutral 90.0 +9,792 26.21% ✗ -
May 18, 2023 May 19, 2023 Melincoff Gwen A Director Neutral 90.0 +9,792 27.99% ✗ -
May 18, 2023 May 19, 2023 SANTINI GINO Director Neutral 90.0 +9,792 16.83% ✗ -
May 18, 2023 May 19, 2023 BOHLIN GAREN G Director Neutral 90.0 +9,792 27.99% ✗ -
Mar 15, 2023 Mar 17, 2023 Tupper Colleen CFO Sell 12.5 -31,640 -23.08% ✓ $752.2K
Mar 1, 2023 Mar 3, 2023 Dreyer Scott EVP & Chief Commercial Officer Sell 26.3 -13,324 -8.99% ✓ $355.8K
Feb 10, 2023 Feb 14, 2023 Smith Thomas B EVP and Chief Medical Officer Neutral 90.0 +31,185 100.00% ✗ -
Feb 10, 2023 Feb 14, 2023 Kuhlmann Shirley R. EVP and General Counsel Sell 100.0 +28,007 25.58% ✓ $1.2M
Feb 10, 2023 Feb 14, 2023 Tupper Colleen CFO Sell 97.5 +46,756 51.78% ✗ $290.3K
Feb 10, 2023 Feb 14, 2023 Ciaffoni Joseph CEO Sell 95.0 +140,087 7.04% ✓ $3.1M
Feb 10, 2023 Feb 14, 2023 Dreyer Scott EVP & Chief Commercial Officer Sell 97.5 +45,408 44.17% ✗ $570.5K
Jan 9, 2023 Jan 11, 2023 Dreyer Scott EVP & Chief Commercial Officer Sell 22.5 -17,834 -14.78% ✓ $488.6K
Dec 22, 2022 Dec 27, 2022 Heffernan Michael Thomas Director Sell 17.5 -25,041 -18.26% ✓ $590.5K
Dec 22, 2022 Dec 27, 2022 Ciaffoni Joseph CEO Sell 47.5 -2,461 -0.98% ✓ $58.3K
Dec 19, 2022 Dec 21, 2022 Heffernan Michael Thomas Director Sell 5.0 -83,964 -49.97% ✓ $1.9M
Dec 19, 2022 Dec 21, 2022 Ciaffoni Joseph CEO Sell 30.0 -17,842 -6.63% ✓ $411.8K
Dec 12, 2022 Dec 14, 2022 Heffernan Michael Thomas Director Sell 5.0 -189,607 -77.18% ✓ $4.2M
Dec 1, 2022 Dec 5, 2022 Ciaffoni Joseph CEO Sell 5.0 -131,053 -32.75% ✓ $3M
Nov 28, 2022 Nov 30, 2022 Ciaffoni Joseph CEO Sell 58.8 -43 -0.01% ✓ $946
Nov 22, 2022 Nov 25, 2022 Ciaffoni Joseph CEO Sell 58.8 -65 -0.02% ✓ $1.4K